Guest Editorial: DIA/HESI/SAPS Conference on Environmental Risk Assessment of Human Medicines (Stockholm, May 22–23, 2006) Mark MontfortsPer SpindlerRich Williams DIA/HESI/SAPS/Conference 30 December 2007 Pages: 129 - 131
Exposure to Pharmaceuticals Present in the Environment Richard T. WilliamsJon C. Cook DIA/HESI/SAPS/Conference 30 December 2007 Pages: 133 - 141
Environmental Effects of Human Pharmaceuticals John Phillip Sumpter DIA/HESI/SAPS/Conference 30 December 2007 Pages: 143 - 147
Environmental Assessment for Human Medicines in the European Union Per SpindlerMark MontfortsJan-Willem van der Laan DIA/HESI/SAPS/Conference 30 December 2007 Pages: 149 - 153
Environmental Assessment of Human Pharmaceuticals in the United States of America Keith WebberPer Spindler DIA/HESI/SAPS/Conference 30 December 2007 Pages: 155 - 157
Environmental Assessment of Pharmaceuticals in Canada: A Regulatory Perspective Andrew Beck DIA/HESI/SAPS/Conference 30 December 2007 Pages: 159 - 162
Regulations and Guidelines on Human Health Products in Japan Yoshitada Yoshioka DIA/HESI/SAPS/Conference 30 December 2007 Pages: 163 - 167
Assessing Environmental Impacts of Veterinary Products: Lessons from VICH Joseph A. Robinson DIA/HESI/SAPS/Conference 30 December 2007 Pages: 169 - 185
A Voluntary Environmental Classification System for Pharmaceutical Substances Bengt Mattson DIA/HESI/SAPS/Conference 30 December 2007 Pages: 187 - 191
Summary of Workshop on Fate of Pharmaceuticals in the Environment Klaus KümmererVirginia L. Cunningham DIA/HESI/SAPS/Conference 30 December 2007 Pages: 193 - 194
Workshop on the Use of Modeling and Monitoring in the Environmental Risk Assessment of Human Medicines Richard Murray-SmithMaria Ramil DIA/HESI/SAPS/Conference 30 December 2007 Pages: 195 - 199
Summary of Workshop on Use of Data Developed during Drug Development for Read across to Environmental Analyses Klaus OlejniczakRichard T. WilliamsPer Spindler DIA/HESI/SAPS/Conference 30 December 2007 Pages: 201 - 202
Summary of Workshop on Environmental Assessment of Human Medicines: Development and Use of Aquatic Toxicity Data Mark H. M. M. MontfortsIngvar BrandtThomas H. Hutchinson DIA/HESI/SAPS/Conference 30 December 2007 Pages: 203 - 209
Summary of Workshop on Mixtures Reinhard LaengeHenry Stemplewski DIA/HESI/SAPS/Conference 30 December 2007 Pages: 211 - 212
Development, Implementation, and Validation of a Capacity Management System Martin D. Hynes IIIRobert D. SwartsJeanette M. Colonna Regulatory 30 December 2007 Pages: 213 - 220
EWOC 2.0: Interactive Software for Dose Escalation in Cancer Phase I Clinical Trials Zhiheng XuMourad TighiouartAndré Rogatko Medical Information 30 December 2007 Pages: 221 - 228
Pharmaceutical Manufacturing Efficiency, Drug Prices, and Public Health: Examining the Causal Links John A. VernonW. Keener HughenAntonio J. Trujillo Medical Information 30 December 2007 Pages: 229 - 239
An Assessment of Preparation Methods and Personnel Requirements in a Medical Information Department during Product Launch Tiffany DonaldChristi MarshLaurel Ashworth Medical Information 30 December 2007 Pages: 241 - 250
Clinical Research Nurses: Roles and Qualifications in South Korea Ihnsook JeongHyun-Sook KangWon-Ock Kim Medical Information 30 December 2007 Pages: 251 - 256
Can Medicare Draw Lessons from Dutch Experience with a National Formulary? Joshua CohenCherie PaquetteCatherine Cairns Medical Information 30 December 2007 Pages: 257 - 272